大型人群队列中首次静脉血栓栓塞后的复发与死亡率
基于特罗姆瑟研究纳入710例首次症状性静脉血栓栓塞(VTE)患者,随访1994-2012年。中位随访7.7年间发生114例复发和333例死亡。总体复发率为每100人年3.9例,但随时间变化大,首年最高。首年全因死亡率为每100人年29.9例。
要点
- 首年VTE复发率为每100人年7.8例(95%CI 5.8-10.6),显著高于后续1-18年的每100人年3.0例(95%CI 2.4-3.8)。
- 首年全因死亡率为每100人年29.9例(95%CI 25.7-34.8),无癌症患者为每100人年23.6例(95%CI 17.8-31.3)。
- 尽管VTE管理进步,首次VTE后首年不良事件发生率仍较高。
核心结论
- 尽管VTE管理取得进展,首次VTE后不良事件发生率仍较高,尤其是首年。
研究设计与样本
- 基于特罗姆瑟研究的大型人群队列,纳入710例首次症状性、客观确诊的VTE患者,随访期为1994-2012年。
主要发现
- 中位随访7.7年(范围0.04-18.2年),共发生114例VTE复发和333例死亡。
- 总体复发率为每100人年3.9例,首年复发率为每100人年7.8例(95%CI 5.8-10.6),后续1-18年复发率为每100人年3.0例(95%CI 2.4-3.8)。
- 首年全因死亡率为每100人年29.9例(95%CI 25.7-34.8),无癌症患者首年全因死亡率为每100人年23.6例(95%CI 17.8-31.3)。
- 患者平均年龄68岁(范围28-102岁),166例(23.4%)在首次VTE时患有癌症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Reports on recurrence and mortality after a first venous thromboembolism (VTE) vary considerably. We describe rates of recurrence and mortality in patients with a first VTE from the Tromsø study. The overall recurrence rate was 3.9 per 100 person-years, but this varied widely with time. Despite advances in VTE management, the rates of adverse events are still fairly high. SUMMARY: Background Previous reports on recurrence and mortality rates after a first episode of venous thromboembolism (VTE) vary considerably. Advances in the management and treatment of VTE during the last 15 years may have influenced the rates of clinical outcomes. Aim To estimate the rates of recurrence and mortality after a first VTE in patients recruited from a large population-based cohort. Method From the Tromsø study, patients (n = 710) with a first, symptomatic, objectively confirmed VTE were included and followed in the period 1994-2012. Recurrent episodes of VTE were identified from multiple sources and carefully validated by review of medical records. Incidence rates and cumulative incidence rates with 95% confidence intervals (CIs) of VTE recurrence and mortality were calculated. Results The mean age of the patients was 68 years (range 28-102 years), and 166 (23.4%) had cancer at the time of first VTE. There were 114 VTE recurrences and 333 deaths during a median study period of 7.7 years (range 0.04-18.2 years). The risk of recurrence was highest during the first year. The overall 1-year recurrence rate was 7.8 (95% CI 5.8-10.6) per 100 person-years (PY), whereas the recurrence rate in the remaining follow-up period (1-18 years) was 3.0 (95% CI 2.4-3.8) per 100 PY. The overall 1-year all-cause mortality rate was 29.9 (95% CI 25.7-34.8) per 100 PY, and in those without cancer the corresponding rate was 23.6 (95% CI 17.8-31.3) per 100 PY. Conclusion Despite advances in VTE management, the rates of adverse events remained fairly high, particularly in the first year following a first VTE.
引用
- Arshad N, Bjøri E, Hindberg K, et al. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost. 2017. PMID: 27943560. doi:10.1111/jth.13587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。